172 related articles for article (PubMed ID: 7088206)
1. [Is bismuth subcitrate an effective drug for the patient with peptic ulcer?].
Brouwers JR; Tytgat GN
Ned Tijdschr Geneeskd; 1982 May; 126(18):795-8. PubMed ID: 7088206
[No Abstract] [Full Text] [Related]
2. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
4. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
[TBL] [Abstract][Full Text] [Related]
5. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
6. The treatment of peptic ulcer.
Barbezat GO
N Z Med J; 1982 Nov; 95(720):813-4. PubMed ID: 6961321
[No Abstract] [Full Text] [Related]
7. De-Nol: a new concept in cytoprotection. Proceedings from an international symposium. Milan, Italy, 13 November 1985.
Scand J Gastroenterol Suppl; 1986; 122():1-53. PubMed ID: 3465025
[No Abstract] [Full Text] [Related]
8. [Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer].
Grigo'rev PIa; Isakov VA; Iakovenko EP
Klin Med (Mosk); 1989 May; 67(5):17-22. PubMed ID: 2671482
[No Abstract] [Full Text] [Related]
9. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
[No Abstract] [Full Text] [Related]
11. [Selective and locally-acting drugs in the treatment of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654
[No Abstract] [Full Text] [Related]
12. Newer drugs in the treatment of peptic ulcer.
Tandon BN
Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076
[No Abstract] [Full Text] [Related]
13. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
14. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine.
Harley H; Alp MH
Med J Aust; 1983 Dec 10-24; 2(12):627-8. PubMed ID: 6366498
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J
Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850
[No Abstract] [Full Text] [Related]
16. Update in treatment of peptic ulcer disease.
Schubert TT
Mo Med; 1984 Nov; 81(11):723-7. PubMed ID: 6095013
[No Abstract] [Full Text] [Related]
17. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
18. Bismuth compounds in the treatment of peptic ulcer: a review.
Nanivadekar SA
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():736-42. PubMed ID: 2092031
[No Abstract] [Full Text] [Related]
19. Colloidal bismuth subcitrate in peptic ulcer--a review.
Tytgat GN
Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
[TBL] [Abstract][Full Text] [Related]
20. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
Lux G
Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
